![Simponi approved for rheumatoid arthritis](https://www.mcknights.com/wp-content/uploads/sites/5/2018/07/5-2-09-simponi-arthritis_52147.jpg)
The Food and Drug Administration has approved rheumatoid arthritis drug golimumab. The product is marketed by Pennsylvania-based Centocor Ortho Biotech Inc. and will be sold under the name Simponi. The medication works by blocking tumor necrosis factor, an inflammation often found in rheumatoid arthritis patients.
http://www.centocor.com/centocor/home.html